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President Sir FARQUHAR BUZZARD, Bart., K.C.V.O., M.D. [May 28, 1935] The Use of Sanocrysin in the Treatment of Pulmonary Tuberculosis By G. GREGORY KAYNE, M.D., M.R.C.P. \I0LLGAARD brought forward the chemical and experimental work relating to sanocrysin in 1924 and he was able at the same time to give Secher's results of the first clinical trials in man. Investigations were initiated without delay and carried on with enthusiasm in many parts of the world. Ten years should, in these circumstances, be sufficient to demonstrate the efficacy of a method of treatment in a disease as common as pulmonary tuberculosis. Unfortunately no unanimity of opinion has been reached. Those who see a tuberculous basis in diseases so widely apart as rheumatoid arthritis and dementia prscox, would use it in almost all illness to which human nature is heir. Others, even in pulmonary tuberculosis, consider it more advantageous to place the gold in the patient's pockets rather than in his veins. And between these two extremes many shades of opinion or differences of practice exist, as regards indications, mode of application, and results obtained. My remarks to-day are not based on experience gained in treating patients myself, but on observations made as the result of personal contact with several European workers. After sketching the outlines of past experimental work, I propose to review briefly the guiding principles of sanocrysin therapy in the centres I visited, and in the light of these, attempt to present conclusions as to indications and mode of application.
Experimental Work It is generally agreed that sanocrysin has no marked effect on tubercle bacilli in vitro. M0llgaard claimed, however, that it has a direct bactericidal effect in the animal body. He adduced at least three arguments in suipport of his opinion. He states [8] that "a quarter, and in some cases one-tenth, of the dose which is without effect on the healthy animal, produces the most severe reactions in the tuberculous organism . . ." these reactions presumably being due to liberation of toxins following destruction of the bacilli, and similar to those following the injection of large doses of tuberculin. Histological examination of the affected organs of
Proceedings of the Royal Society of Medicine treated animals, dying after severe reactions, showed morphological forms suggesting such disintegration. And, finally, the beneficial effect in regard to reactions following the use of a serum prepared by immunizing healthy animals with defatted formalintreated tubercle bacilli seemed to favour his hypothesis. It was remarkable, however, that the injection of the gold salt at the same time as the bacilli did not prevent the development of tuberculous lesions (Madsen and M0rch [7] ). In addition, the appreciation that the metal itself might play a r6le in producing reactions, their diminished frequency with smaller doses, and the varying results obtained with the serum, led to rejection of the theory of a direct bactericidal action and to the abandonment of the use of serum. Those admitting the beneficial effect of sanocrysin-and as will be seen below, experimental evidence, in addition to M0llgaard's, exists in support of it-invoke the possibility of sanocrysin acting as an aid or stimulant to the natural tissue-defences. M0llgaard [10] himself, in 1928, questions how sanocrysin acts and points to the unexplained mechanism of chemotherapy in general.
In 1925, 0. Bang [2] carried out experiments in calves but could not confirm M0llgaard's curative findings. In spite of the latter's criticism [9] of certain details in Bang's work, Bang maintained [3] that M0llgaard's results were due to the varying resistance of animals to abnormal (attenuated) tubercle bacilli, and that the animals used for controls might already have been infected and therefore be more resistant. MHadsen and M0rch [6] , in 1926, showed that in rabbits, when slightly virulent bacilli were used, all the animals had reactions after small doses of sanocrysin, and the serum proved no protection, but the gold was curative. After infection with highly virulent bacilli, there were no reactions with sanocrysin; serum was therefore unnecessary, and to obtain curative results large doses of the gold salt were needed. Repeating their experiments in collaboration with 0. Bang in 1928, these authors [7] could not, however, again obtain the positive results in rabbits. K. A. Jensen [5] failed to obtain definite results and could not, like M0llgaard, even produce in the rabbits the chronic predominantly pulmonary lesions. In England, Lyle Cummins [4] , in 1926, concluded that sanocrysin used in appropriate doses and at an early stage in the disease had a markedly favourable action upon the course of experimental tuberculosis in the rabbit, and that the favourable effects varied inversely with the virulence of the infecting bacillus and the size of the infecting dose. Finally, more recently, Atkin (1931) [1] , working with dead bacilli injected intravenously in rabbits, found that repeated injections of sanocrysin protected them from the lethal action of an intravenous injection of old tuberculin about one month later, while control animals succumbed. He states that his experiments prove that sanocrysin exerts an inhibitory effect on tuberculous lesions, apart from any bactericidal action it may have on the living tubercle bacillus.
It will be seen that there exists no clear experimental basis for the use of sanocrysin in pulmonary tuberculosis and that further work in this connexion is to be encouraged. Nevertheless, in view of the benefit derived from other remedies used empirically at first, complete rejection of its use does not appear justified. In fairness to M0llgaard and considering the many types of cases in which the gold salt has been administered, the following statement [8] from his paper in 1925 should be quoted: "It may therefore be expected that the best effect of the sanocrysin serum treatment in the human subject will be obtained in cases of the exudative pneumonic type. . . . As, however, our present treatment, inclusive of artificial pneumothorax, fails to give definite results in very many of these cases, the attempt to found a chemotherapy on sanocrysin would not have been in vain, if it should be limited to such cases." 88 1464 89
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During the last few years Mollgaard has concentrated on the bacteriology of tuberculosis and has not carried out any further experimental work with sanocrysin. His views on indication and mode of action are to-day identical with those indicated above.
Sanocrysin Therapy in Denmark. In Denmark, Knud Secher's work must be considered first. In view of the critical remarks which follow, it should be pointed out that even an unbiassed perusal of his publications and a few weeks' personal contact may be insufficient fairly to appraise ten years' work. He is a general physician in a general hospital, whose patients constitute mainly observation cases, which, after a short stay, invariably pass on to a sanatorium. Although many of the patients are traced by Secher afterwards, it is clear that these circumstances do not favour a just appreciation of the part played by sanocrysin remotely, or even immediately, in view of the associated rest. Moreover, in his results published in 1932, 114 patients are stated [12] to have been rendered symptomless, but of these no less than 80 were classified before treatment as early or moderately severe cases without tubercle bacilli. Secher believes that sanocrysin causes a liberation of toxins which accounts for all the reactions that follow. He therefore bases his initial dosage on the assumption that in " open cases" the toxins can be excreted by the air-passages and therefore larger doses are permissible, while in " closed cases " smaller doses are indicated because the toxinshaving no outlet pass into the blood-stream. For the same reason smaller dosage is advisable in extensive than in localized lesions, in recent than in old-standing cases. His indications are wide: advanced disease, tuberculosis of other organs (especially of the intestine), but not of the larynx, being almost the only contra-indications. He even advises its use in old fibroid cases and, in addition, employs it frequently in pleurisy. The difficulty of deciding the presence of an associated pulmonary lesion and the greatly varying statistics published as to the ultimate prognosis of pleural effusions do not appear to justify Secher's enthusiasm in this connexion [13] . His initial dosage still remains the highest administered at present, for he argues, on the basis of his conception of the cause of reactions, that it is doubtful whether they should be avoided, and in fact states [12] : "On the basis of the experiments I made I believe that the reaction following treatment greatly activates the cure." He begins with 025, 035, or 0'5 grm., rising to a dose of about 1 grm., but rarely reaching a total of more than 5 or 6 grm. This fact in the light of his statement' tends to suggest that the beneficial results obtained by Secher are due to a form of " shock-therapy " rather than to any specific effect of the gold. This is supported by the finding of congestive areas around tuberculous lesions in the fatal cases which occurred in the days when even larger doses were used. I must, however, also admit that I was impressed by seeing several patients who had had pyrexial reactions associated with albuminuria, or erythema, on more than one occasion, in whom subsequent injections of even larger doses produced no reaction at all. The greater frequency of erythemas in the early stage of sanocrysin treatment, also noted by Say6 and others, argues against the gold as their cause. It may also be pertinent to quote here Professor Knud Faber's statement to me that while he could in no way be dogmatic as to the value of sanocrysin, he felt convinced that in the early days of large dosage remarkable curative results, not seen now, were occasionally obtained.
Gravesen's use of sanocrysin at Vejlefjord Sanatorium is of a different character. He considers that the ideal indication is the early exudative lesion, whether occurring by itself or in association with older processes-when, however, a palliative effect only can be expected. The type of material he deals with tends to make him use sanocrysin as a valuable aid in collapse-therapy-to clear one side before attempting surgical intervention on the opposite older lesion, or to treat a contralateral extension of disease after artificial pneumothorax or thoracoplasty. The presence of cavitation, even in a unilateral exudative process, compels the institution of an artificial pneumothorax, although sanocrysin may be given in addition. Old-standing disease with fibrosis or cavitation should be considered a contra-indication. His dosage is moderate. Beginning with 01 grm. the dose is gradually increased, a one-day interval being allowed for each 0'1 grm., in the last dose given-unless reactions occur-to a final dose of 0 -75 grm., or occasionally to 1 grm. About 2 5 grm. are administeredduring the first month and the total course of about 5 grm. is repeated afterwards. Reactions are avoided as far as possible, but in a series of 500 cases two fatalities have occurred; one patient whose prognosis was already unfavourable died from acute nephritis, and the other succumbed to purpura two weeks after returning home.
Two other workers in Copenhagen who have used sanocrysin extensively-C. H. Wuirtzen and Permin-did not appear to have very definite convictions as to its efficacy. Wurtzen employs it less than formerly, and Permin, who favours small doses at regular intervals, could only state that in view of the possible benefit to be derived, he "did not feel justified in withholding it" from suitable patients.
In the centres I visited in Norway and Sweden (Stockholm, Gotenburg, Lund, Uppsala, Oslo) sanocrysin has not been employed since the years of large dosage and severe reactions, and this applies to some workers in Denmark (e.g. 0. Lassen, in Aarhus) who have not given the newer dosage and clearer indications a trial up to the present. Sanocrysin in Barcelona. Professor Say6's work with sanocrysin in Barcelona has attracted much international attention. Two months in his clinics have shown me that added to his enthusiasm is a real attempt to work out the indications and mode of application in a careful and conscientious manner. His results as regards efficacy are probably more telling than those in other countries in view of the inadequate dispensary and sanatorium organization and the low economic level in Spain.
Less than one-fifth of his patients can have sanatorium or any form of rest treatment after completion of the course of sanocrysin, during which, however, rest is obtained either in hospital or in their homes. In less than one-third of the sanocrysin patients is some form of collapse-therapy associated. While his indications are based on the effect of the sanocrysin on the early exudative lesion (and he draws special attention to the visibility of the pulmonary network through the X-ray shadow in this connexion), he believes its use to be justified in lesions associated with " acute" cavities, and as a trial measure in moderately advanced caseous and ulcerative cases. He regards as contra-indications old-standing cases with much fibrosis and those showing marked toxsmia or severe tuberculous lesions elsewhere.
While administering large single doses ultimately-sometimes as much as 1 grm.he begins with a small dose, 0-1 grm. or less, guiding himself in this, in subsequent dosage, and as regards intervals, by the weight of the patient, the type of disease, and the reactions obtained. Thus a larger dose, initially and ultimately, will be used for the pure exudative lesion when a curative effect is expected, but small doses will be used in the chronic case with cavitation where the treatment is one " of trial" (tratamiento de pruteba). The total amount given varies considerably, 90 1466 Section of Medicine but may reach over 20 grm., as Say6 considers that a second course, at least, is advisable even in those patients who improve markedly after the first. Of special interest are Say6's views on reactions. He divides them into three types. Small or single rises of temperature, slight transient albuminuria, and fleeting erythemas are to be regarded as focal reactions and the next dose given after disappearance of the symptoms. Gastro-enteric disturbances, dermatitis, and persistent albuminuria indicate metallic intolerance and call for an increased interval and the same, or a smaller, dose afterwards. Repetition or multiplicity of intolerance symptoms are due to metallic saturation and compel cessation of treatment. Say6 claims to obtain only 10% intolerance symptoms and rarely experiences saturation syndromes which generally indicate that the patient's prognosis was already unfavourable.
Mention must be made of Say6's use of sanocrysin for ambulant patients. Included in this series are many patients with small apical shadows in whom the treatment might perhaps be regarded as prophylactic rather than curative, yet in some of them tubercle bacilli have been found in the gastric lavage. His dosage here is smaller-rarely higher than 0 4 grm.-and it is to be noted that the percentage of intolerance symptoms is no higher than in the bed patients.
In the clinic of the late Professor Leon Bernard, at the Dispensaire L6on Bourgeois of the Laennec Hospital, several hundreds of out-patients, one-third of whom did not stop their work, have now been treated with sanocrysin (or rather crisalbine). Beginning with 0. 1 grm., a dose of 0-25 is reached within two weeks, and this dose is repeated weekly for several months. If no improvement results, or in febrile patients, the dose is increased to 0*5 grm. Ten per cent. only of "accidental and incidental diseases" (Charles Mayer) due to the treatment are claimed and this satisfactory result is attributed to the use of 10% calcium gluconate as a solvent for the crisalbine.
Discussion and Conclusions.
In attempting to formulate guiding principles for the use of sanocrysin in pulmonary tuberculosis, failing any conclusive experimental basis of its mode of action, appeal must be made in a certain measure to common sense. The difficulty of collecting reliable evidence as to its effect in man is almost insuperable, for while many individual cases showing improvement or arrest following the use of sanocrysin alone can be brought forward, it is clear that, until such time as the prognosis of every patient can be foretold with accuracy, exact control series-and therefore the r6le played by the sanocrysin-will be unobtainable. In these circumstances we are not justified in withholding the gold salt from those types of cases in which in the past its use has been associated with definite improvement, and the red herring of nettoyage radiologique occurring in untreated patients should not be allowed to influence the decision. On the other hand, there seems little justification for the use of sanocrysin as a placebo-for this will imply its use in chronic, fibro-ulcerative cases in which improvement will be difficult to assess, where the treatment may be associated with episodes like htmoptysis, and as the result of which the mode of treatment is likely to be brought into discredit. I would summarize the clear indications as follows, severe constitutional symptoms to be regarded as a relative contra-indication:
(1) Recent lesions (i.e. those associated with symptoms of not more than three or four months' duration) of the exudative type (showing fluffy-edged soft X-ray shadows). When' cavitation is present, sanocrysin may be used, but an artificial pneumothorax should be induced without delay. It is not uncommonly stated that such patients should first be given a trial of three months' sanatorium rest before active measures are adopted. While firmly believing in the efficacy of absolute rest, I can see that this procedure may be somewhat dangerous, in the working and middle classes at any rate, unless our institutional accommodation is sufficient to enable the improvement which may occur at the end of three months to be followed up with continued rest (perhaps six months, a year, or even longer), sufficient to achieve arrest.
(2) The second indication is a recent exudative lesion occurring in association with old-standing disease. If this arises in the contralateral side, sanocrysin may be used to eradicate the recent lesion before collapse measures are attempted on the more chronic side, or to deal with a recent exacerbation when the other lung is already collapsed. If serial X-rays are employed, " fresh spreading disease " (Gravesen) on the same side as an old lesion may be detected and sometimes controlled by means of sanocrysin.
(3) A third indication, which I offer tentatively, is the use of sanocrysin for patients in whom suggestive shadows are found during routine examinations (e.g. students, nurses), in the absence of definite clinical evidence of activity, to whom one does not feel justified in recommending a long period of rest which may interfere with their professional career. Observation might be combined with judicious ambulatory gold therapy. This problem will probably loom larger when routine examinations of certain sections of the population are instituted in this country.
As regards dosage, the method of large initial doses appears too dangerous, in view of the severe and occasionally fatal reactions, even if the gravity of the milder reactions has been exaggerated. In a disease which is rarely sufficiently acute for a few days' delay in treatment to matter, there is everything to gain and little to lose by commencing with a small dose, say 0 05 grm., and gradually increasing it by 0 05 grm., and then by 0-1 grm. till a dose of 065 grm. is reached. The rule applied by Gravesen as regards intervals appears to be as rational as any, and there seems little foundation for complicated calculations and fine differences. Again, in the present state of our knowledge, Say6's views as regards reactions and their influence on dosage and intervals appear to be those most acceptable. It is important not to be deterred too soon by mild reactions. Unfortunately, in view of the difficulty in determining when an erythema will develop into a persistent dermatitis, one's situation may often be that between the devil and the deep sea. Finally, if no obvious improvement has occurred after four or six weeks, or about 4 grm. of sanocrysin, there seems little justification for continuing this treatment.
In concluding, may I again emphasize that my remarks are based on observation of the work of others and can at the best only lead to tentative conclusions which I hope, however, may serve to stimulate interest in what is still a highly controversial subject.
